← Main Site About Agenda Partner Request Invitation Request Invitation
Back to Pharmalyzer Global
🍳 Invitation-Only Executive Breakfast

Accelerating Translational Drug Discovery Through AI & Biomarkers

A curated gathering of 25–30 senior pharmaceutical and biotechnology leaders for focused discussion, strategic insight, and meaningful relationship-building.

📍 San Diego, CA
🗓 September 17, 2026
8:00 AM – 11:00 AM
Event Countdown
102 Days
00 Hours
00 Mins
00 Secs
👥
25–30 Executives Carefully curated, invitation-only attendance
🏛
Premium Venue Executive setting in San Diego, CA
🤝
1 Strategic Partner Only Exclusive industry partnership opportunity
🔬
AI & Biomarker Focus Drug discovery, translational medicine, precision R&D
Executive Networking
Invitation Only 25–30 Senior Leaders

Not a Traditional Conference

The Pharmalyzer Discovery Breakfast is designed exclusively for senior pharmaceutical and biotechnology professionals. With a carefully curated audience of 20–30 executives, the event prioritizes quality conversations, practical insights, and strategic networking over large-format presentations.

🎯

Senior Industry Leaders

Meet peers and decision-makers from leading pharmaceutical and biotechnology organizations.

💬

Strategic Discussions

Executive-level conversations addressing real-world drug discovery challenges and opportunities.

🔗

High-Value Networking

Build relationships through curated introductions and focused, facilitated networking time.

🔭

Future-Focused Insights

Explore emerging approaches in AI, translational medicine, biomarkers, and precision drug development.

Accelerating Translational Drug Discovery Through AI & Biomarkers

Modern drug discovery faces increasing pressure to improve translational success, reduce development timelines, and make better early-stage decisions. This executive breakfast explores how artificial intelligence, biomarkers, computational biology, and translational science are helping organizations improve predictability and therapeutic outcomes.

🤖

AI-Driven Target Discovery

Exploring how machine learning and AI platforms are identifying and validating novel therapeutic targets with greater speed and confidence.

🧬

Biomarker Strategies for Better Decision Making

Leveraging biomarkers to improve go/no-go decisions, enhance patient stratification, and reduce late-stage failures across pipelines.

🔄

Translational Medicine Challenges & Opportunities

Bridging the gap between preclinical research and clinical application — and where the industry's biggest translational bottlenecks lie.

💻

Computational Biology & Predictive Models

How computational approaches are reshaping drug design, ADMET prediction, and multi-omics integration in modern R&D.

📊

Improving Preclinical Success Rates

Strategies and tools that are genuinely moving the needle on preclinical-to-clinical translation success rates across therapeutic areas.

🔮

Future Trends in Drug Discovery

A forward-looking conversation on what drug discovery will look like in 2030 — from autonomous research to personalized medicine at scale.

Event Agenda

A focused three-hour executive programme designed to maximise discussion, relationship-building, and forward-thinking insight.

08:00 – 08:30
🤝 Networking

Executive Breakfast & Networking

Premium breakfast experience with facilitated introductions and structured networking among senior industry leaders.

08:30 – 08:40
🎤 Opening

Welcome & Industry Outlook

Opening remarks and industry perspectives on the current state and future direction of translational drug discovery.

08:40 – 09:20
🏛 Executive Panel

Executive Panel Discussion

Accelerating Translational Drug Discovery Through AI & Biomarkers

Industry leaders discuss practical applications, real-world challenges, and emerging opportunities in AI-enabled drug discovery and biomarker-driven R&D strategy.

09:20 – 09:40
🔁 Roundtable

Executive Roundtable Discussion

Interactive discussion focused on discovery bottlenecks, AI adoption challenges, and practical biomarker integration strategies across different organizational contexts.

09:40 – 09:55
⭐ Partner Insight

Strategic Industry Partner Insight Session

Expert perspectives from the exclusive Strategic Industry Partner on enabling faster and more effective drug discovery outcomes.

09:55 – 10:25
🔥 Fireside Chat

Fireside Chat

What Will Drug Discovery Look Like in 2030?

A forward-looking conversation with a senior industry leader exploring the technologies, strategies, and organizational models that will define the next decade of pharmaceutical R&D.

10:25 – 11:00
🤝 Networking

Curated Executive Networking

Facilitated networking session with strategic introductions and opportunity to continue conversations from the morning's discussions.

Senior Pharmaceutical & Biotechnology Leaders

This event is exclusively designed for senior decision-makers and scientific leaders within pharmaceutical and biotechnology organisations. All attendance requests are reviewed and subject to approval.

🔬

VP Drug Discovery

🧪

Head of Discovery Research

🔁

Head of Translational Medicine

💻

Director Computational Biology

📊

Biomarker Strategy Leaders

🎯

Precision Medicine Leaders

🏛

Senior Preclinical R&D Executives

⚗️

Chief Scientific Officers

🧬

Drug Discovery Scientists

🔭

Translational Research Leaders

🤖

AI & Data Science Leaders

💊

Therapeutic Area Heads

Executive Speakers

We are in the process of confirming senior industry leaders and scientific experts to lead discussions across our panel, roundtable, and fireside sessions. Speaker announcements coming soon.

🎤
Panel Speaker
To Be Announced
🔥
Fireside Chat
To Be Announced
🔁
Roundtable Moderator
To Be Announced
Strategic Partner Speaker
To Be Announced

Be the first to know when speakers are confirmed

Request Your Invitation
Premium Executive Venue

Premium Executive Setting, San Diego

📍 San Diego, California  |  September 17, 2026
🔒 Venue Announced to Confirmed Attendees

The breakfast will be hosted at a premium executive venue in San Diego designed to encourage discussion, networking, and collaboration in a comfortable and professionally curated environment.

Specific venue details — including address, parking, and logistics — will be shared exclusively with confirmed attendees ahead of the event.

Request Invitation

Why Partner With This Event

The Pharmalyzer Discovery Breakfast offers an exclusive opportunity to connect with a carefully selected audience of pharmaceutical and biotechnology executives at one of the most focused senior gatherings in the drug discovery calendar.

Strategic Partner Benefits

As the exclusive Strategic Industry Partner, your organisation gains unrivalled visibility and access to 25–30 senior drug discovery decision-makers in an intimate, high-trust environment.

Executive Brand Visibility across all event materials
Dedicated Insight Session (15-minute partner spotlight)
Curated Introductions to target attendee profiles
Premium Networking Access throughout the entire event
Post-Event Visibility via Pharmalyzer Global channels
Relationship Development with senior industry leaders
⭐ Only 1 Partner Selected

Become the Exclusive Strategic Industry Partner

Only one Strategic Industry Partner will be selected for this event. Speak with our team to explore whether this opportunity aligns with your organisation's goals.

Request Your Invitation

To maintain the quality of discussion and networking, attendance is strictly limited to approximately 25–30 senior industry professionals. All registrations are subject to review and approval by the Pharmalyzer Global team.

⚠️ Limited Places Remaining — Apply Early
1
Submit Your Request Complete the invitation form with your details and areas of interest.
2
Application Review Our team reviews each request to ensure the right seniority and sector mix.
3
Confirmation & Venue Details Approved attendees receive confirmation and full event logistics by email.

Invitation Request Form

All fields required. Subject to approval.

By submitting, you agree to be contacted by Pharmalyzer Global regarding this event. Attendance is subject to approval.

Join Senior Leaders Shaping the Future of Drug Discovery

Be part of an exclusive executive gathering exploring how AI, biomarkers, and translational medicine are transforming therapeutic innovation. San Diego, September 17, 2026.